Single cell and spatial full-length transcriptome library building method based on next-generation sequencing and application thereof
By performing intramolecular cyclization and fragmentation processing of cDNA, combined with the enrichment technology of specific molecular tags, the problem of not being able to capture the full-length information of mRNA in the prior art is solved, and single-cell and The space-wide full-length transcription library is established to improve detection efficiency and accuracy.
Patent Information
- Application Number
- CN202410996942.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-24
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-07-24
AI Technical Summary
The existing second-generation sequencing method cannot capture the entire mRNA full-length information, resulting in the inability to build a single-cell and spatial full-length transcriptome library.
By intramolecular cyclization of cDNA with single-cell/space tags at the 3' or 5' end, fragmentation and linker sequence addition using transposase, enrichment and second-generation sequencing, combined with specific molecular tags, Obtain complete mRNA full-length information.
The library building of single-cell and spatial full-length transcriptomes was achieved based on second-generation sequencing, which improved detection efficiency and accuracy, could accurately and effectively enrich target fragments, and perform single-molecular-level full-length transcriptome splicing.
Smart Images

Figure CN118932499A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the field of gene engineering technology, and in particular to a single-cell and spatial full-length transcriptome library construction method based on second-generation sequencing and an application thereof. Background Art
[0002] Next-generation sequencing (NGS), also known as high-throughput sequencing, is a DNA sequencing technology developed based on PCR and gene chips. It can quickly sequence the base pairs of DNA or RNA samples. NGS supports a wide range of applications, including gene expression profiling, chromosome counting, epigenetic change detection and molecular analysis, and is promoting the development and realization of the future of personalized medicine. It determines the gene sequence by sequencing multiple small DNA fragments in parallel. Single-cell transcriptome sequencing and spatial transcriptome sequencing are emerging sequencing methods under the second-generation sequencing. Single-cell transcriptome sequencing (Single-cell RNA-sequencing) refers to a new technology for high-throughput sequencing and analysis of RNA at the single-cell level. Unlike the results obtained by conventional tissue or cell population sequencing, single sequencing can deeply explore specific information. Spatial transcriptomics is a technology that analyzes and describes the expression profile of specific cell types in the dimension of space to understand the expression differences between organs, tissues and pathological states. It can parse the transcripts of tissues in different spatial locations.
[0003] However, the existing methods based on second-generation sequencing either only capture the 3' end information of mRNA or only capture the 5' end information, and both cannot achieve the capture of the full-length information of the entire mRNA. At present, there are two main methods based on intramolecular circularization: one is the blunt end direct connection scheme; the other is to use the recombinase system to circularize large DNA fragments. The blunt end direct connection scheme can only rely on the collision probability of the large fragment DNA molecule's own distortion, so the circularization efficiency is low, usually less than 10%. There are also some problems in the circularization of large DNA fragments based on the recombinase system. For example, a large proportion of linker fragments with recombination sites in different directions at both ends will be generated, resulting in the inability to carry out recombination; in addition, the recombination efficiency of the recombinase system in vitro is not high. These factors lead to the circularization efficiency of the entire system not exceeding 10%. The technology that is similar to this method is full-length transcriptome sequencing based on third-generation sequencing. Although it can capture the full-length information of mRNA, the length of mRNA is relatively short (generally around 1.5kb), which is not very consistent with the fragment length required by conventional third-generation sequencers (more than 10-20kb). Therefore, there are often problems such as low detection efficiency and low accuracy, and its sequencing price is also relatively expensive.
[0004] The existing technology cannot capture the full-length information of the entire mRNA, so it is impossible to build a library of single-cell and spatial full-length transcriptomes based on second-generation sequencing. Therefore, how to use second-generation sequencing to obtain complete mRNA single-cell and spatial full-length transcriptomes has become a problem that needs to be solved urgently. Summary of the invention
[0005] In order to solve the above technical problems, the present invention provides a single-cell and spatial full-length transcriptome library construction method based on second-generation sequencing and its application, which can realize the capture of the entire mRNA full-length information, and based on the single-cell / spatial labels and specific molecular labels shared in the 3' and 5' end sequencing data, single-cell and spatial full-length transcriptome libraries can be constructed on the basis of second-generation sequencing.
[0006] To achieve this object, the present invention adopts the following technical solutions:
[0007] In a first aspect, the present invention provides a single-cell and spatial full-length transcriptome library construction method based on next-generation sequencing, the steps of the library construction method comprising:
[0008] (S1) intramolecularly circularizing the cDNA with a single cell tag or a spatial tag and a specific molecular tag at the 3' end or the 5' end;
[0009] (S2) fragmenting the cDNA molecules circularized in step (S1) with a transposase and adding adapter sequences;
[0010] (S3) Screening, amplification and next-generation sequencing of the fragmented cDNA in step (S2).
[0011] The present invention creatively transforms and intramolecularly circularizes the normal 3'-end (or 5'-end) single-cell / space transcriptome library cDNA molecules, so that the 5'-end is connected with the single-cell / space tag and the specific molecular tag at the 3'-end of the original cDNA molecule, and then specifically enriches the 5'-end cDNA, the single-cell / space tag and the specific molecular tag and performs second-generation sequencing, so that not only the 5'-end cDNA information can be obtained, but also the full-length cDNA can be assembled using the single-cell / space tag and the specific molecular tag based on the original 3'-end cDNA information, thereby obtaining the complete full-length mRNA information.
[0012] Preferably, in step (S1), the fragment size of the cDNA molecule is 50-5000 bp, for example, it can be 50 bp, 100 bp, 1000 bp, 2000 bp, 3000 bp, 4000 bp or 5000 bp, etc.
[0013] Preferably, in step (S1), the fragment size of the single cell tag is 5-100 bp, for example, it can be 5 bp, 10 bp, 20 bp, 40 bp, 60 bp, 80 bp or 100 bp, etc.
[0014] Preferably, in step (S1), the fragment size of the spatial tag is 5-100 bp, for example, it can be 5 bp, 10 bp, 20 bp, 40 bp, 60 bp, 80 bp or 100 bp, etc.
[0015] Preferably, in step (S1), the fragment size of the specific molecular tag is 5-100 bp, for example, it can be 5 bp, 10 bp, 20 bp, 40 bp, 60 bp, 80 bp or 100 bp, etc.
[0016] Preferably, in step (S1), linkers with deoxyguanosine are added to both ends of the cDNA molecule, and the linker with deoxyguanosine at the 3' end is labeled with biotin.
[0017] Preferably, in step (S1), the intramolecular cyclization step comprises:
[0018] (1) amplifying, purifying and recovering the modified cDNA molecules;
[0019] (2) using an enzyme with deoxyuridine cleavage function to cut the modified cDNA molecule to obtain a large cDNA fragment with a gap, which is then purified and recovered after incubation;
[0020] (3) Using ligase, the large cDNA fragment with a gap is intramolecularly circularized, purified and recovered to obtain circularized cDNA.
[0021] Preferably, in step (1), the amplification primers include SEQ ID NO:1 and SEQ ID NO:2.
[0022] Preferably, in step (2), the enzyme having deoxyuridine cleavage function includes USER enzyme and UDG enzyme.
[0023] In the present invention, an enzyme with deoxyuridine cleavage function is used to cut the deoxyguanosine linkers added to both ends of cDNA to form sticky ends. The sticky ends at both ends are connected to form circularized DNA. After fragmentation, the 3' end contains biotin, and the DNA information at the 5' end can be obtained by enrichment with streptavidin magnetic beads.
[0024] Preferably, in step (2), the incubation temperature is 35-40°C, and the incubation time is 20-40 min. The 35-40°C may be, for example, 35°C, 36°C, 37°C, 38°C, 39°C or 40°C, etc. The 20-40 min may be, for example, 20 min, 25 min, 30 min, 35 min or 40 min, etc.
[0025] Preferably, in step (3), the ligase includes T4 ligase, T7 DNA ligase, E. coli DNA ligase and Taq DNA ligase.
[0026] Preferably, in step (3), the cyclization temperature is 20-30°C, and the cyclization time is 10-14h. The 20-30°C may be, for example, 20°C, 22°C, 24°C, 26°C, 28°C or 30°C, and the 10-14h may be, for example, 10h, 11h, 12h, 13h or 14h.
[0027] Preferably, step (3) further comprises digesting the uncircularized linear DNA contained in the obtained circularized cDNA.
[0028] In the present invention, the uncircularized linear DNA is digested to reduce the influence of the uncircularized linear DNA on subsequent fragmentation. After the linear DNA is fragmented, the complete information of both ends cannot be obtained, so it needs to be digested before fragmentation.
[0029] Preferably, the digestion step comprises: adding a linear DNA digestion enzyme to the circularized cDNA obtained in step (3), incubating, and then purifying and recovering the cDNA.
[0030] Preferably, the incubation temperature is 35-40°C, and the incubation time is 30-90 min. The 35-40°C may be, for example, 35°C, 36°C, 37°C, 38°C, 39°C or 40°C, etc. The 30-90 min may be, for example, 30 min, 40 min, 50 min, 60 min, 70 min, 80 min or 90 min, etc.
[0031] Preferably, in step (S2), the transposase fragmentation step comprises: fragmenting the circularized cDNA using a transposase and adding adapters to obtain fragmented cDNA containing adapters.
[0032] Preferably, the transposase comprises the Tn5 enzyme.
[0033] Preferably, the fragmentation temperature is 30-60°C, and the incubation time is 10-60 min; the 30-60°C may be, for example, 30°C, 40°C, 50°C or 60°C, etc. The 10-60 min may be, for example, 10 min, 20 min, 30 min, 40 min, 50 min or 60 min, etc.
[0034] Preferably, in step (S3), the steps of screening, amplification and next-generation sequencing include:
[0035] (A) The fragmented cDNA containing the adapter and biotin modification is enriched using magnetic beads, and cDNA fragments are obtained after incubation;
[0036] (B) The obtained cDNA fragments were amplified and screened before being subjected to next-generation high-throughput sequencing.
[0037] Preferably, in step (A), the magnetic beads include streptavidin magnetic beads.
[0038] Preferably, in step (A), the incubation temperature is 20-30°C, and the incubation time is 20-40 min. The 20-30°C may be, for example, 20°C, 22°C, 24°C, 26°C, 28°C or 30°C. The 20-40 min may be, for example, 20 min, 25 min, 30 min, 35 min or 40 min.
[0039] Preferably, in step (A), the incubation is rotational incubation, and the rotation speed is 1-500 rpm, for example, it can be 1 rpm, 100 rpm, 200 rpm, 300 rpm, 400 rpm or 500 rpm, etc.
[0040] Preferably, in step (B), the library construction primers required for amplification include SEQ ID NO:3 and SEQ ID NO:4.
[0041] Preferably, in step (B), the fragment screening is to screen out fragments containing single cell tags or spatial tags, as well as fragments with specific molecular tags and 5' end cDNA, so as to perform splicing of the full-length transcriptome based on the corresponding sequence information obtained by subsequent sequencing.
[0042] In the second aspect, the present invention provides an application of the single-cell and spatial full-length transcriptome library construction method based on second-generation sequencing described in the first aspect in the construction of single-cell and spatial transcriptome sequencing libraries.
[0043] Compared with the prior art, the present invention has at least the following beneficial effects:
[0044] 1. The present invention uses intramolecular ligation to cleverly connect the 5' cDNA and 3' molecular tags that cannot be detected simultaneously in conventional second-generation high-throughput sequencing, thereby making it possible to detect the 5' cDNA and 3' molecular tags based on conventional second-generation high-throughput sequencing.
[0045] 2. The present invention uses streptavidin magnetic beads to specifically enrich the 5'-end cDNA containing biotin tags and the 3'-end molecular tag fragments after fragmentation. This method can accurately and effectively enrich the target fragments, is simple to operate, and is not easy to destroy the fragment information.
[0046] 3. The present invention creatively adds single-cell / spatial tags and specific molecular tags common to the 3'-end and 5'-end sequencing data, and can perform splicing of the full-length transcriptome at the single-molecule level. BRIEF DESCRIPTION OF THE DRAWINGS
[0047] Figure 1 This is a schematic diagram of the principles of the single-cell and spatial full-length transcriptome library construction method that relies on second-generation sequencing.
[0048] Figure 2 is the cDNA fragment size distribution diagram.
[0049] Figure 3 This is the fragment size distribution diagram after cDNA self-circularization.
[0050] Figure 4 It is the fragment size distribution diagram of the library.
[0051] Figure 5 It is a statistical diagram of the distribution of single-cell and spatial transcriptome sequencing fragments on the genome.
[0052] Figure 6 This is a clustering result diagram of 3' end, 5' end and 3'+5' end sequencing analysis. DETAILED DESCRIPTION
[0053] The technical solution of the present invention is further described below in conjunction with the accompanying drawings and through specific implementation methods. However, the following examples are only simplified examples of the present invention and do not represent or limit the scope of protection of the present invention. The scope of protection of the present invention shall be subject to the claims.
[0054] Various instruments, consumables and reagents not specifically described in the examples of the present invention are conventional commercial products in the field and can be obtained through commercial channels. The specific experimental materials and their sources listed in the following examples are merely exemplary and are not intended to limit the present invention. Materials with the same or similar types, models, qualities, properties or functions as the following tissues, cells, reagents and instruments can be used to implement the present invention.
[0055] The sources of reagents used in the following examples are:
[0056] Biotin: Sangon Biotech (Shanghai) Co., Ltd.
[0057] USER enzyme: NEB (New England Biolabs).
[0058] T4 DNA ligase: NEB (New England Biolabs).
[0059] Transposase: Nanjing Novozymes Biotech Co., Ltd.
[0060] Single cell labeling: Sangon Biotech (Shanghai) Co., Ltd.
[0061] Space tag: Shanghai Bioengineering Co., Ltd.
[0062] Example 1
[0063] This example designs primers
[0064] The library construction principle of the present invention is as follows Figure 1 As shown, first, the cDNA of mouse brain tissue obtained based on conventional single-cell and spatial transcriptome technology is amplified by a circular primer with U base and biotin modification, so that the 3' end of all the fragments produced by amplification are modified with U base and biotin. The U base can be specifically cut by certain enzymes (such as USER enzyme), and the sticky ends produced by the cutting can be connected intramolecularly (such as T4 DNA ligase). The connected product is interrupted by transposase (Tn5) and has a unique adapter sequence at both ends. Since the part with the tag sequence in the interrupted product is biotin-modified, it can be easily enriched using streptavidin magnetic beads. The enriched product is then amplified with a specific library primer to obtain the cDNA sequence and the molecular tag part with the 5' end, and it is subjected to second-generation high-throughput sequencing to obtain the sequence information of the cDNA 5' end and the molecular tag part. Since both the 3' and 5' end sequencing data contain specific molecular tags (UMIs), the 3' sequencing data obtained in conventional single-cell and spatial transcriptome sequencing can be further combined to perform sequencing fragment splicing based on common UMIs, thereby ultimately obtaining single-molecule-level full-length transcriptome information with single-cell or spatial accuracy.
[0065] Based on the above principle, amplification sequences 1 and 2 and library construction primers 1 and 2 were designed. SEQ ID NO.1-SEQ ID NO.2 are amplification sequences 1 and 2, respectively. SEQ ID NO.3-SEQ ID NO.4 are the upstream primer and downstream primer of library construction primer 1, respectively. SEQ ID NO.5-SEQ ID NO.6 are the upstream primer and downstream primer of library construction primer 1, respectively. The specific sequences are shown in Table 1:
[0066] Table 1
[0067] Primer name sequence name Sequence information (5'→3') Primer set 3 SEQ ID NO.3: AATGATACGGCGACCACCGAGATCTACACTA Primer set 4 SEQ ID NO.4: GATCGCTCGTCGGCAGCGTCAGATGTGTAT Primer set 5 SEQ ID NO.5: CAAGCAGAAGACGGCATACGAGATTCG Primer set 6 SEQ ID NO.6: CCTTAGTCTCGTGGGCTCGGAGATGT
[0068] Primer set 1 is AU-SEQ ID NO.1, wherein U is deoxyuridine, SEQ ID NO.1: CGACGCTCTTCCGATCT, and the seventh base T from 5'→3' is a biotin-labeled base.
[0069] Primer set 2 is AU-SEQ ID NO.2, wherein U is deoxyuridine, SEQ ID NO.2: GTGGTATCAACGCAGAGT.
[0070] Example 2
[0071] In this example, intramolecular cyclization
[0072] (1) Add U base and biotin
[0073] The mouse brain tissue cDNA obtained based on conventional single-cell and spatial transcriptome technology was amplified using the bio-synthesized amplification sequences 1 and 2 of the Bio-engineering Biotechnology. The cDNA contains single-cell tags, spatial tags, and specific molecular tags, which can be used for subsequent single-cell transcriptome sequencing and spatial transcriptome sequencing. Amplification sequences 1 and 2 both include U bases, and the sticky ends produced by USER enzyme cleavage can be used for DNA cyclization, while biotin is used to screen 3' fragments and molecular tags. The following system was used for amplification, and U bases and biotin were added to the cDNA.
[0074] Table 2
[0075] Reagent name Addition amount 5× High-Fidelity Polymerase Buffer 10μL dNTP Mix (10mM) 1μL Amplified sequence 1 (10 μM) 2μL Amplified sequence 2 (10 μM) 2μL cDNA 100ng U base tolerant high fidelity amplification enzyme 1μL <![CDATA[ddH2O]]> Add to 50 μL
[0076] The specific length distribution of the input cDNA is as follows Figure 2As shown. The 5× high-fidelity polymerase buffer used is 5×Uc Buffer for Library Amplification, and the U base-tolerant high-fidelity amplification enzyme used is PhantaUc Super-Fidelity DNA Polymerase. The above system was amplified, and the amplification program was: 95°C~3min; 5 cycles (98°C~10s, 65°C~45s, 72°C~3min); 4°C was maintained.
[0077] Purify the amplified product. Add 50 μL beads to the amplified product, mix thoroughly and incubate at room temperature for 10 minutes, then place on a magnetic rack, remove the liquid after it is clear, add 200 μL 80% alcohol to wash the beads twice, dry at room temperature for 5 minutes, add 50 μL ddH2O to elute for 5 minutes, place on a magnetic rack, and carefully pipette the liquid into a new tube after the liquid is clear.
[0078] (2) Add U base digestion enzyme to form sticky ends
[0079] The cDNA with U base and biotin added was added to a centrifuge tube according to the system shown in Table 3 below, and placed in a PCR instrument at 37°C for 30 minutes. The cDNA after incubation was taken out and beads purified. The purification process was as described in step (1).
[0080] Table 3
[0081]
[0082]
[0083] (3) Circular ligation of sticky ends
[0084] The obtained cDNA with sticky ends was circularized and connected, and added to a centrifuge tube according to the system shown in Table 4 below, and placed in a PCR instrument at 25°C for incubation for 12 hours. The cDNA after incubation was taken out, purified, and then analyzed in a fully automatic nucleic acid protein analysis system. The specific results are as follows Figure 3 As shown in the figure, it can be clearly seen that there are two obvious peaks in the fragment distribution, one is a peak of uncircularized fragments with a length of about 800 bp, and the other is a peak of successfully circularized cDNA products with a length of about 1500 bp.
[0085] Table 4
[0086] Components content cDNA obtained in step (2) 50μL 10×T4 DNA Ligase Buffer 30μL T4 DNA ligase (2000U / μL) 7μL <![CDATA[ddH2O]]> Replenish to 300 μL
[0087] (4) Digestion of linear cDNA
[0088] The obtained circularized cDNA was added into a centrifuge tube according to the system shown in Table 5 below, placed in a PCR instrument at 37° C., and incubated for 1 hour. The cDNA after incubation was taken out and purified.
[0089] Example 3
[0090] This example performs DNA fragmentation, enrichment and library amplification
[0091] (1) DNA fragmentation
[0092] Take 50 ng of the circularized DNA obtained in Example 2, add 50 μL of Tn5 enzyme (TTE Mix V5) and 20 μL of 5× fragmentation buffer (5×TTBL), add ddH2O to 100 μL, and place at 55°C for fragmentation for 20 min. TTE Mix V5 and 5×TTBL reagents are both from Novizan DNA Library Prep Kit V2 for Illumina TD502 kit.
[0093] (2) DNA enrichment
[0094] Add 20 μL C1 beads (streptavidin magnetic beads) to the above fragmentation product and rotate at room temperature for 30 min to bind and enrich the biotin-containing and linker fragments, then add 500 μL elution buffer (EB buffer) to wash for 5 min to initially remove impurities, and then add 100 μL ddH2O to wash for 5 min to completely remove residual impurities.
[0095] (3) Amplification
[0096] Add the 3'-end-containing DNA enriched in step (1) into a centrifuge tube according to the system shown in Table 5 below.
[0097] Table 5
[0098] Reagent name Addition amount 2× High-Fidelity Polymerase Mix 10μL P5 (10 μM) 2μL Ad2.1 (10 μM) 2μL C1 beads \ <![CDATA[ddH2O]]> Add to 50 μL
[0099] The 2× high-fidelity polymerase mixture used was 2×KAPA HIFI Master mix. The above system was amplified, and the amplification program was: 95° C.~3 min; 10 cycles (98° C.~10 s, 65° C.~45 s, 72° C.~3 min); 4° C. maintained.
[0100] The amplified product was bidirectionally purified. Add 30μL beads to the above amplified product, mix thoroughly and incubate at room temperature for 10 minutes. Then place it on a magnetic rack, remove the beads and retain the supernatant after the liquid is clarified, then add 10μL beads to the supernatant, mix thoroughly and incubate at room temperature for 10 minutes. Then place it on a magnetic rack, remove the supernatant after the liquid is clarified, add 200μL 80% alcohol to wash the magnetic beads twice, dry at room temperature for 5 minutes, add 50μL ddH2O to elute for 5 minutes, place it on a magnetic rack, and carefully pipette the liquid into a new tube after the liquid is clarified. The resulting library fragment size is mainly distributed between 300bp and 600bp, as shown below. Figure 4 shown.
[0101] Example 4
[0102] This example performs second-generation high-throughput sequencing
[0103] The library obtained above was subjected to conventional PE150 second-generation high-throughput sequencing, and the reads obtained after sequencing were aligned back to the corresponding reference genome. The distribution results of the reads on the gene after alignment are as follows: Figure 5 As shown in FIG. 1 , the reads obtained by conventional 3'-end sequencing are mainly distributed at the 3'-end of the gene, while the reads obtained by the 5'-end sequencing after circularization adopted in the present invention are mainly distributed at the 5'-end of the gene. Combining the reads of the above two methods simultaneously achieves balanced coverage of the gene at the 5' and 3' ends. Figure 6 As shown, this method can construct single-cell maps and spatial maps regardless of 3'-end sequencing reads or 5'-end sequencing reads, and simultaneously combining double-end sequencing reads can construct more detailed single-cell and spatial maps.
[0104] In summary, the method of the present invention can perform single-cell and spatial sequencing of complete mRNA, which makes up for the defect that the second-generation sequencing cannot be used to perform single-cell and spatial sequencing of complete mRNA in the prior art. This method has the characteristics of high detection efficiency and high accuracy.
[0105] The applicant declares that the above is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Those skilled in the art should understand that any changes or substitutions that can be easily thought of by those skilled in the art within the technical scope disclosed by the present invention shall fall within the protection scope and disclosure scope of the present invention.
Claims
1. A method for building libraries of single-cell and spatial full-length transcriptomes based on next-generation sequencing, characterized in that: The steps of the library construction method include: (S1) intramolecularly circularizing the cDNA with a single cell tag or a spatial tag and a specific molecular tag at the 3' end or the 5' end; (S2) fragmenting the cDNA molecules circularized in step (S1) with a transposase and adding adapter sequences; (S3) Screening, amplification and next-generation sequencing of the fragmented cDNA in step (S2).
2. The library construction method according to claim 1, characterized in that: In step (S1), the fragment size of the cDNA molecule is 50-5000 bp; Preferably, in step (S1), the fragment size of the single cell tag is 5-100 bp; Preferably, in step (S1), the fragment size of the spatial tag is 5-100 bp; Preferably, in step (S1), the fragment size of the specific molecular tag is 5-100 bp; Preferably, in step (S1), linkers with deoxyguanosine are added to both ends of the cDNA molecule, and the linker with deoxyguanosine at the 3' end is labeled with biotin.
3. The library construction method according to claim 1 or 2, characterized in that: In step (S1), the intramolecular cyclization step comprises: (1) amplifying, purifying and recovering the modified cDNA molecules; (2) using an enzyme with deoxyuridine cleavage function to cut the modified cDNA molecule to obtain a large cDNA fragment with a gap, which is then purified and recovered after incubation; (3) Using ligase, the large cDNA fragment with a gap is intramolecularly circularized, purified and recovered to obtain circularized cDNA.
4. The library construction method according to claim 3, characterized in that: In step (1), the amplification primers include SEQ ID NO: 1 and SEQ ID NO: 2; Preferably, in step (2), the enzyme having deoxyuridine cleavage function includes USER enzyme and UDG enzyme; Preferably, in step (2), the incubation temperature is 35-40° C., and the incubation time is 20-40 min.
5. The library construction method according to claim 3 or 4, characterized in that: In step (3), the ligase includes T4 ligase, T7 DNA ligase, E. coli DNA ligase and Taq DNA ligase; Preferably, in step (3), the cyclization temperature is 20-30°C and the cyclization time is 10-14h; Preferably, step (3) further comprises digesting the uncircularized linear DNA contained in the obtained circularized cDNA; Preferably, the digestion step comprises: adding a linear DNA digestion enzyme to the circularized cDNA obtained in step (3), incubating, and then purifying and recovering the cDNA; Preferably, the incubation temperature is 35-40° C., and the incubation time is 30-90 min.
6. The library construction method according to claim 1 or 2, characterized in that: In step (S2), the transposase fragmentation step includes: using transposase to fragment the circularized cDNA and add adapters to obtain fragmented cDNA containing adapters; Preferably, the transposase comprises the Tn5 enzyme; Preferably, the fragmentation temperature is 30-60°C, and the incubation time is 10-60 min.
7. The library construction method according to claim 1 or 2, characterized in that: In step (S3), the steps of screening, amplification and next generation sequencing include: (A) The obtained cDNA fragments are enriched with magnetic beads, and fragmented cDNA containing biotin modification is obtained after incubation; (B) The obtained cDNA fragments were amplified and screened before being subjected to next-generation high-throughput sequencing.
8. The library construction method according to claim 7, characterized in that: The magnetic beads in step (A) include streptavidin magnetic beads; Preferably, in step (A), the incubation temperature is 20-30°C and the incubation time is 20-40min; Preferably, in step (A), the incubation is rotational incubation, and the rotation speed is 5-100 rpm.
9. The library construction method according to claim 7 or 8, characterized in that: In step (B), the library construction primers required for amplification include SEQ ID NO: 3 and SEQ ID NO: 4; Preferably, in step (B), the fragment screening is to screen out fragments containing single cell tags or spatial tags, and fragments with specific molecular tags and 5' end cDNA.
10. Application of a single-cell and spatial full-length transcriptome library construction method based on second-generation sequencing according to any one of claims 1-9 in the construction of a single-cell and spatial transcriptome sequencing library.
Citation Information
Patent Citations
Single cell full-length transcript library building and sequencing method
CN115873922A
Tagging nucleic acid molecules from single cells for phased sequencing
US20200231964A1
Method for constructing sequencing library, obtained sequencing library and sequencing method
US20210214783A1
Method for constructing sequencing library, obtained sequencing library and sequencing method
WO2020061903A1
